Table 3 Involvement of renal arteries
All patients (n = 141) | RAI ≥ grade 3 (n = 28) | RAI < grade 3 (n = 113) | p value | |||||
|---|---|---|---|---|---|---|---|---|
n | % | n | % | n | % | |||
Females | 33 | 23% | 9 | 32% | 24 | 21% | 0.2233 | |
Age in years, median (range) | 68 (27–91) | 67 (52–85) | 68 (27–91) | 0.7781 | ||||
eGFR in mL/min/1.73 m2, median (range), (n = 134) | 84 (25–253) | 70 (25–138) | 88 (30–253) | 0.0137 | ||||
Creatinine in μmol/L median (range), (n = 134) | 83 (12–205) | 95 (50–205) | 82 (12–158) | 0.0903 | ||||
CRP in mg/L, median (range) | 8.490 (0–289) | 9.375 (0–55) | 8.270 (0–289) | 0.8483 | ||||
Arterial hypertension | 83 | 59% | 22 | 79% | 61 | 54% | 0.0192 | |
Diabetes | 54 | 38% | 10 | 36% | 44 | 39% | 0.8303 | |
Indication for MRA | ||||||||
Suspected PAD | 12 | 9% | 1 | 4% | 11 | 10% | 0.4599 | |
Known PAD | 129 | 91% | 27 | 96% | 102 | 90% | ||
Fontaine stage IIa | 3 | 3% | 0 | 0% | 3 | 3% | 0.0684 | |
Fontaine stage IIb | 61 | 52% | 18 | 72% | 43 | 47% | ||
Fontaine stage III | 10 | 9% | 2 | 8% | 8 | 9% | ||
Fontaine stage IV | 43 | 37% | 5 | 20% | 38 | 41% | ||
Presence of accessory renal artery | 24 | 17% | 6 | 21% | 18 | 16% | 0.5742 | |